Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 9, 2013

Eisai, Emergent BioSolutions, Gilead, Helsinn, Merck Serono, Novartis, QLT

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase II Cyclacel posts MDS trial results . . . read more Emergent gets positive results in CLL trial . . . read more QLT doses first IDA patient . . . read more Phase III Merck Serono publishes data for NSCLC trial . . . read more Filings Helsinn, Eisai CINV treatment to be reviewed . . . read more Approvals Gilead’s HCV treatment approved . . . read more Health Canada approves Novartis meningitis vaccine . . . read more Post-Approval Five-year data support Novartis’ Tasigna ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters